Who owns PegmaTiss BioTech?

PegmaTiss BioTech is currently owned by Erganeo, through Erganeo, since 2023.

When did Erganeo acquire PegmaTiss BioTech?

Erganeo acquired PegmaTiss BioTech in 2023 (active for 3 years).

Home/Companies/Healthcare/PegmaTiss BioTech

PegmaTiss BioTech

Healthcare·

France·Active·3yr hold

PegmaTiss BioTech is a healthcare company, headquartered in France.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Investor

Erganeo

Key facts

HQFrance

SectorHealthcare

Bioresorbable bone-substitute biotech founded October 2023; Erganeo exclusive license signed December 10 2024.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Erganeo

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings